Alzheimer's Disease and other Dementias
Another “Alzheimer's in a Dish” Model
In October 2014, we posted an article on ThirdAge.com about an “Alzheimer’s in a Dish Model” (http://thirdage.com/node/2884631) developed at Massachusetts General Hospital. Now, in December 2014, the search for a living laboratory model of human neurons in the grip of Alzheimer’s disease (AD)–the so-called “Alzheimer’s in a dish”–has a new candidate. In work presented at the meeting of the American Society for Cell Biology/International Federation for Cell Biology (ASCB/IFCB) in Philadelphia, Håkan Toresson and colleagues of Lund University in Sweden reported success in creating induced neurons that model Alzheimer’s by starting with fibroblasts taken from skin biopsies.
A release from ASCB explains that the differentiated cells express a full range of normal neuronal markers. Significantly, all the neurons derived from fibroblasts including those taken from patients diagnosed with AD, express the proteins classically associated with the neurodegenerative disorder including amyloid beta (Aβ) and the microtubule-associated protein tau, giving researchers a ready comparison between AD patients and the normal elderly.
All the fibroblast samples in Toresson’s study came from patients enrolled in a large, long-term clinical research program on dementia called the Swedish BioFinder Study. The biopsies are linked to patient histories and results from batteries of longitudinal tests covering behavior, spinal fluid biochemistry, and brain imaging results including PET and MRI scans. The researchers subjected the fibroblast samples to growth factor treatment and transduction by three transcription factors, Ascl1, Brn2 and Myt1l, that induced differentiation into nerve cells. So far Toresson reports success in 12 out of 12 attempts to create induced neurons from the BioFinder samples, giving the researchers a cell biological library of neurons from elderly Swedes who exhibit signs of sporadic AD, familial AD, or robust cognitive health.
The relationship of Aβ and tau in AD progression are still hotly disputed but accumulations of tau-based tangles and Aβ plaques in the brain at autopsy are currently the only clear diagnostic of the disease. But sampling AD-damaged neurons in living patients is impossible. Using animals to model human diseases such as cancer has been a powerful instrument in bioscience but no good animal model of AD, which is first seen as impairment of human cognitive function, has been found. “Alzheimer’s in a dish” or, in Toresson’s studies, a series of dishes could be that long-awaited model system.